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Background: Important knowledge about the role of vitamin A in vertebrate heart development has been
obtained using the vitamin A-deficient avian in ovo model which enables the in vivo examination of very early
stages of vertebrate heart morphogenesis. These studies have revealed the critical role of the vitamin A-active form,
retinoic acid (RA) in the regulation of several developmental genes, including the important growth regulatory
factor, transforming growth factor-beta2 (TGFβ2), involved in early events of heart morphogenesis. However, this in
ovo model is not readily available for elucidating details of molecular mechanisms determining RA activity, thus
limiting further examination of RA-regulated early heart morphogenesis. In order to obtain insights into RA-regulated
gene expression during these early events, a reliable in vitro model is needed. Here we describe a cell culture that
closely reproduces the in ovo observed regulatory effects of RA on TGFβ2 and on several developmental genes linked
to TGFβ signaling during heart morphogenesis.
Results: We have developed an avian heart forming region (HFR) cell based in vitro model that displays the
characteristics associated with vertebrate early heart morphogenesis, i.e. the expression of Nkx2.5 and GATA4, the
cardiogenesis genes, of vascular endothelial growth factor (VEGF-A), the vasculogenesis gene and of fibronectin
(FN1), an essential component in building the heart, and the expression of the multifunctional genes TGFβ2 and
neogenin (NEO). Importantly, we established that the HFR cell culture is a valid model to study RA-regulated
molecular events during heart morphogenesis and that the expression of TGFβ2 as well as the expression of several
TGFβ2-linked developmental genes is regulated by RA.
Conclusions: Our findings reported here offer a biologically relevant experimental in vitro system for the elucidation
of RA-regulated expression of TGFβ2 and other genes involved in vertebrate early cardiovascular morphogenesis.
Keywords: Chicken heart forming region cells, in vitro culture, Retinoic acid, TGFβ2, Early cardiovascular developmentBackground
Vitamin A and its active form, retinoic acid (RA) play an
important role in cell proliferation, differentiation, mor-
phogenesis and organogenesis during vertebrate develop-
ment [1]. RA is involved in embryonic cell patterning,
myogenic differentiation, chondrogenesis, central nervous
system development and cardiovascular development* Correspondence: inese.cakstina@lu.lv
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unless otherwise stated.[1-3]. RA regulates gene expression by binding specific
nuclear transcription factors, retinoic-acid-receptors
(RARs) and retinoid-X-receptors (RXRs), which interact
with cognate promoter sequences, retinoic acid response
elements (RAREs) [4,5] in target genes.
The cardiovascular system is the first functioning system
to develop in the vertebrate embryo. At various stages
during avian embryogenesis the defects in cardiovascular
development can be caused both by a deficiency or an ex-
cess of vitamin A [6].
During a short time span during avian embryonic devel-
opment, at the Hamburger and Hamilton stage 8 (HH 8)l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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heart morphogenesis and for the survival of the avian em-
bryo [3,6,7]. In the absence of vitamin A at this critical de-
velopmental window, morphogenesis of the posterior
region of the primitive heart is impaired, the newly devel-
oping inflow tracts (IFTs) close inappropriately, and the
sino-atrial tissue fails to differentiate [7]. Vitamin A-
deficient (VAD) embryos die by day four of development
with gross abnormalities in the developing heart and cen-
tral nervous system. The abnormal development can be
prevented by the administration of all-trans-RA to the
VAD embryo during or prior to the critical RA-requiring
developmental window at the 4–5 ss of embryogenesis
[7].
The transforming growth factor beta (TGFβ) super-
family is a large group of multifunctional, structurally
related cytokines that are major regulators of normal
growth and development in multi-cellular organisms
[8,9]. Expression of TGFβs and their cell surface recep-
tors is universal and widespread throughout develop-
ment. TGFβ canonical signaling pathway involves the
intracellular mediators SMADs [10,11], although alter-
native options, e.g. the MAPK/ERK pathway, have also
been identified [12]. TGFβs are expressed in three
isoforms, TGFβ1, TGFβ2 and TGFβ3, each having spe-
cific, non-overlapping roles in cellular functions [13].
TGFβ2 is most strongly linked to heart morphogenesis
[14]. TGFβ2-null mice exhibit cardiac, lung, cranio-
facial, limb, eye, ear and urogenital developmental
defects [15].
TGFβ2 is expressed early in chick embryogenesis. At
the 3–4 ss, it is localized in the notochord, neural tube
and splanchnic mesoderm, the developmental progenitor
of the heart forming regions [16]. Later in embryogen-
esis, TGFβ2 is expressed in the heart inflow tracts during
the early looping stages, in the atrio-ventricular canal
and in the heart outflow tract [11]. TGFβ2 is required to
secure epithelial-mesenchymal transition during the de-
velopment of endocardial cushions [17].
Regulation of TGFβ signaling by RA is well docu-
mented [9,11,13,14]. Depending on the cell type, RA can
either induce or repress TGFβ expression [18]. Recent in
ovo studies with quail embryos demonstrated that RA
signaling is required for the normal development of the
avian heart IFTs and that TGFβ2 is involved in this RA-
regulated event. This was evidenced by the observation
that in the absence of RA TGFβ2 was over-expressed in
all embryonic cell layers, suggesting that RA acts as a
negative regulator of TGFβ2 synthesis during embryo-
genesis [14]. Similarly, elevated ectopic TGFβ2 protein
accounts for the heart septation defects and abnormal-
ities in the outflow tracts of RA receptor mutant mice
[1,19]. Since the TGFβ2 gene does not have RA response
elements [10], the mechanism of regulation of TGFβ2by RA is expected to be indirect and warrants further
investigation.
The aim of this research was to develop a reliable in
vitro model for the study of RA-regulated TGFβ2 ex-
pression during early vertebrate heart morphogenesis.
Studies of transgenic mice with knock-outs or mutations
of the RARs have provided important information about
the role of TGFβ2 in RA-regulated events during ad-
vanced stages of heart formation, but have not addressed
the role of this important growth regulator in the critical
early events of heart morphogenesis. Using an in vitro
chicken embryo heart-forming region (HFR) cell culture
model we provide new insights into the role of TGFβ2
during the initial molecular events of heart building.
In order to obtain a better understanding of TGFβ2
function during early cardiovascular development as well
as to expand the application of the model, we examined
several genes known to be RA-regulated during embry-
onic cardiovascular development and also linked to
TGFβ2. Vascular endothelial growth factor (VEGF-A)
was a gene of great interest, since in vivo work has
shown that the formation of the endothelial linkage of
the heart to the primordial vasculature is an integral part
of the early heart building events and that this process is
RA-regulated and indirectly linked to TGFβ2 [6,14]. Fur-
thermore, embryonic vasculogenesis and angiogenesis
are known to be RA-regulated and thus likely involve
VEGF-A [20,21]. Another RA-regulated gene is fibronec-
tin (FN) [21,22], an extracellular matrix component es-
sential for many morphogenesis events and a prominent
component of the interface between the endoderm and
mesoderm of the HFR, thus involved in building the em-
bryonic cardiovascular system. Additionally, it has been
reported that FN is a target of TGFβ signaling pathway
[23]. Similarly, neogenin (NEO) is known to be induced
by TGFβ signaling [23]. This multifunctional develop-
mental protein was initially studied in neurogenesis [24],
but recent studies have shown it to be an important
regulator of organogenesis in the embryo [24]. Further-
more, NEO is a receptor for the bone morphogenesis
proteins (BMPs) [25]. Since BMP-2 is regulated by RA
during in ovo heart morphogenesis [26], the above ob-
servations warranted an examination of potential links
of NEO to the RA-regulated heart morphogenesis.
In this paper we describe the development of a
chicken embryo HFR cell culture to obtain insights into
RA-regulated TGFβ2 signaling during the initial stages
of heart morphogenesis under conditions where the con-
centration of RA is easily modified and RA is the only
modulator during the growth of the culture. The model
will allow the elucidation of the molecular mechanisms
of signal transduction by TGFβ2 as well as of other im-
portant genes involved in RA-regulated early heart
morphogenesis.
Table 1 Numbers of chicken HFR explants forming
contractile tissue aggregates
Developmental stage
Media 1–2 ss 3–5 ss 7–10ss
DMEM 12%*, (1 of 8) 14%, (1 of 7) 0%, (0 of 4)
Endo-Grow 37%, (3 of 8) 78%, (7 of 9) 25%, (1 of 4)
The total number of explants placed in culture media is shown in parentheses.
*Percentage of explants forming contractile tissue aggregates within 24 h of
cultivation. Experimental details are described in Methods.
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Development of chicken HFR explant and cell culture
model
Explants of the HFR (Figure 1A) tissue from 1–10 ss
embryos were obtained after 36 to 42 h incubation of
freshly fertilized eggs at 37°C and placed in separate
wells on 24-well plates. DMEM/10% FBS medium was
used to propagate all types of adherent cells; Endo-Grow
medium was used to promote growth of endothelial
lineage cells. Contractile cardiomyocytes (Figure 1B,
Additional file 1) were observed after 24 h of cultivation
in both media, although the development of contractile
tissue in DMEM medium was less efficient in compari-
son to that in Endo-Grow.
After one day of incubation, the formation of contract-
ile tissue from the 1–2 ss explants was greater in the
Endo-Grow medium as compared to that grown in
DMEM medium (Table 1). The greatest amounts of con-
tractile cardiomyocytes were formed when explants from
3–5 ss embryos were cultured in Endo-Grow medium.
The capacity of explants to develop contractile tissue di-
minished significantly using later stage embryos.
In RT-PCR assay, HFR cells from explants (n = 10–15)
of 3–5 ss embryos were grown in Endo-Grow media and
gave strong intensity bands for the mRNAs of the
VEGF-A, cardiac transcription factors GATA4 and
Nkx2.5 genes, all known to be involved in cardiovascular
morphogenesis. HFR cells grown in DMEM produced
weak bands for VEGF-A and Nkx2.5 and no bands for
GATA4 transcripts (Figure 2).
Homeobox gene (HoxB1) is involved in early develop-
ment of vertebrate embryos and is regulated by RA both
in vitro [27] and in vivo [28]. HoxB1 has RA response el-
ements within its promoter sequence and thus is a direct
RA target gene [27].Figure 1 Development of chicken embryo HFR explant in culture. (A,
explant from 4–5 ss embryo; (B) 4–5 ss heart forming region explant after
borders of contractile tissue developed within a day in culture (see Additio
documented using video camera. hfr, heart forming region; ss, somite stagWhen RA was added to the medium, HoxB1 gene
mRNA expression increased 15 times and 78 times in
Endo-Grow media supplemented with 10 nM and 100
nM RA, respectively (Figure 3).
Effect of exogenous RA on TGFβ2 gene and protein
expression in cultured HFR cells
Chicken HFR cells were grown in DMEM and in Endo-
Grow media supplemented with exogenous RA at a
concentration of 10 nM (which approximates the con-
centration of RA in the early avian embryo [29], or at the
excess level of 100 nM. Cell growth medium was col-
lected after 3 d of cultivation and used for TGFβ2 ELISA
assay on the same day.
Figure 4 shows that the accumulation of total TGFβ2
protein and mRNA was suppressed at both 10 nM and
100 nM RA concentrations in comparison to controls
without added RA. When RA was added, TGFβ2 protein
decreased by 50% in the cultures grown in DMEM and
by 60% and 80% when grown in Endo-Grow medium
(Figure 4A). TGFβ2 mRNA synthesis was also decreased
in the presence of exogenous RA. In DMEM media the
accumulation of TGFβ2 transcripts was reduced by ap-
proximately 35% with both RA concentrations; in Endo-left) Chicken embryo at 4 ss; (A, right); dissected heart forming region
one day of cultivation in Endo-Grow medium. Red lines mark the
nal file 1). Contractile tissues were observed by microscopy and
e. Scale bars, 1 mm.
Figure 2 Expression of heart development marker genes in
chicken heart forming cell culture. Primary heart forming region
(HFR) cells from 3–5 ss chicken embryos were cultured in DMEM
and Endo-Grow medium and analyzed for VEGF-A, GATA4 and
Nkx2.5 mRNA after 3 d in culture. 30 cycles of PCR amplification
were run with cDNA isolated from 150,000 HFR cells. β-actin was
used as a reference.
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http://www.biomedcentral.com/1471-213X/14/10Grow media TGFβ2 transcripts were reduced by 40% at
10 nM RA and by 60% at 100 nM RA in comparison to
controls without added RA (Figure 4B).
Effect of exogenous RA on the expression of TGFβ/SMAD
regulated genes and on VEGF-A mRNA synthesis
The expression of FN1, NEO and VEGF-A genes
characterize the development of extracellular matrix,
neuronal tube and vascular endothelium, respectively,
within the embryonic tissue. All these processes contrib-
ute to heart morphogenesis. The expression of FN1 and
NEO genes is known to be up-regulated by TGFβ
through the SMAD signaling pathway in human fibro-
blast culture [23]. If in the chicken primary HFR cell cul-
tures these genes were to function as in the human
fibroblasts, then the addition of RA, known to down-
regulate TGFβ2 in the avian embryo [14], would alsoEn
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Figure 3 Expression of HoxB1 in chicken heart forming cell
culture is responsive to presence of retinoic acid (RA) activity.
Primary heart forming region cells from 2–6ss chicken embryos were
cultured in Endo-Grow media in presence of RA. Relative quantification
of HoxB1 mRNA in comparison to control cells with no added RA.
Standard deviations are indicated by error bars. The differences in
comparison to the control at significance level of p < 0.005 are marked
by (**); at p < 0.0001 by (***).cause a decrease in FN and NEO expression. However,
there was a statistically significant increase in FN1
mRNA in HFR cells when cultivated in either DMEM or
Endo-Grow medium in the presence of exogenous RA
(Figure 5A). In contrast, NEO mRNA expression in
HFR cells decreased in the presence of exogenous RA
(Figure 5B), paralleling the down-regulation of TGFβ2
expression observed earlier (Figure 4). This response
was most pronounced in cells cultured in Endo-Grow
medium, where NEO mRNA concentration decreased to
51% and 34% of the mRNA levels observed in controls
cultured without RA supplementation. NEO gene ex-
pression in cells grown in DMEM in the presence of
exogenous RA resulted in a slight decrease at 10 nM
RA, while the decrease at 100 nM RA was not statisti-
cally significant.
VEGF-A mRNA expression in the HFR cells cultured
in DMEM with 10 nM RA or 100 nM RA was increased
by 42% and 78%, respectively in comparison to controls
without supplemented RA. The effect was even more
pronounced when the cells were cultured in Endo-Grow
medium, as there was a 135% increase in the VEGF-A
mRNA expression with 10 nM RA and a 235% increase
in the presence of 100 nM RA (Figure 6).
Discussion
There have been many studies on the role of retinoids in
vertebrate heart development [30], however only a few
have addressed early heart morphogenesis during physio-
logically relevant conditions [3,6]. The present study for
the first time offers a biologically significant and valid in
vitro primary cell culture model from early stage chicken
heart forming regions (HFRs) that can be used to study
vertebrate molecular mechanisms regulated by RA under
conditions that closely mimic early events of vertebrate
in vivo heart morphogenesis. The model is based on the
published in ovo observations that in the avian embryo
the requirement for RA begins at the 4–5 somite stage
(ss) of neurulation [31,32]; this is also the time when
heart morphogenesis is initiated and when the presence
of RA is absolutely essential for normal embryonic devel-
opment to take place [7].
Since vertebrate early heart development is compar-
able across species, the avian embryo offers an ideal
model to study this most important early developmental
event. To offer an alternative to the in vivo model for
studies of retinoid function during early stages of heart
morphogenesis, our strategy was to utilize the know-
ledge obtained from the in ovo studies to produce an in
vitro model that could mimic the in ovo model system.
We accomplished this goal by isolating HFR cells from
3–5 ss normal chicken embryos and culturing them
under conditions that generate tissue characteristics and
biological responses in the presence of retinoic acid. It is
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Figure 4 Retinoic acid regulates TGFβ2 in chicken heart forming cell culture. Primary heart forming region cells from 3–5 ss chicken
embryos were grown in culture for 3 d in either DMEM or Endo-Grow (Endo) media in the presence or absence of added retinoic acid (RA).
(A) Relative quantification of TGFβ2 total protein in the cultivation media in comparison to control cells with no added RA. (B) Relative quantification
of TGFβ2 mRNA in comparison to control cells with no added RA. Standard deviations are indicated by error bars. The differences in comparison to the
control at significance level p < 0.05 are marked by (*), at p < 0.005 by (**); at p < 0.0001 by (***).
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http://www.biomedcentral.com/1471-213X/14/10important to note that for the in vitro system described
here it is critical to harvest the HFR tissue during the
narrow 3–5 ss developmental window, as pointed out
above.
We established that the cultured cells exhibited the ex-
pected characteristics of heart tissue, i.e. forming con-
tractile tissue after 24 hr of growth in culture (Table 1,
Figure 1B, Additional file 1), expressing the cardiogenic
gene Nkx2.5, the cardiogenic transforming factor
GATA4 and the vascular endothelial growth factor
VEGF-A (Figure 2). Next, it was important to verify the
responsiveness of the cultured cells to the vitamin A-
active form, retinoic acid (RA). Although the Endo-
Grow medium that was chosen for culturing the cellsFN1
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Figure 5 Retinoic acid regulates the expression of FN1 and NEO in ch
from 3–5 ss chick embryos were cultured for 3 d in either DMEM or Endo-
(A) Relative quantification of FN1 mRNA in comparison to FN1 mRNA in co
in comparison to NEO mRNA in control cells with no added RA. Standard d
the control at significance level p < 0.05 are marked by (*); at p < 0.005, bycontained 0.1 nM RA, this level is significantly lower
than the physiological level of RA reported for the nor-
mal early avian embryo, i.e. 5 nM [29], thus the expres-
sion of some RA-regulated genes may be weak in these
cultures; the addition of 10 nM RA would be close to
the physiological level of the early avian embryonic cells.
To ascertain that the chicken HFR cell culture is in-
deed a valid in vitro model for the elucidation of RA-
regulated molecular events during early vertebrate em-
bryogenesis, we modulated the expression of HoxB1, a
direct RA target gene [27], in response to the presence
of RA in the culture media (Figure 3) and verified that
the cell culture represents a reliable system for the pro-
posed studies.NEO
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Figure 6 Retinoic acid regulates the expression of VEGF-A in
chicken heart forming cell culture. Primary heart forming region
cells from 3–5 ss chicken embryos were cultured for 3 d in either
DMEM or Endo Grow (Endo) media in the presence or absence of
added retinoic acid (RA). Relative quantification of VEGF-A mRNA in
comparison to VEGF-A mRNA in control cells with no added RA.
Standard deviations are indicated by error bars. Differences in
comparison to the controls at significance level p < 0.05 are marked
by (*); at p < 0.005, by (**).
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forming cell culture model for studying RA-regulated
heart morphogenesis, we next examined in this model
the expression of some of the genes that had been re-
ported to be regulated by RA during early in ovo heart
morphogenesis [6].
We focused on TGFβ2 because it is intricately in-
volved in RA-regulated early heart morphogenesis and
shares many global regulatory characteristics with RA
[6]. Furthermore, endogenous RA is a critical negative in
vivo regulator of TGFβ2 during avian embryogenesis.
TGFβ2 mRNA and protein concentrations are increased
in the vitamin A-deficient (VAD) quail embryo, and sup-
plying a physiological amount of RA to the VAD embryo
decreases and thus normalizes the expression of TGFβ2
[14]. In line with the reported in ovo observations [14],
the presence of 10 or 100 nM RA in HFR cell culture
caused a decrease in TGFβ2 mRNA and protein concen-
trations in the cultured cells (Figure 4). This finding pro-
vides evidence that the chicken HFR cell culture is a
valid biological model to further examine the interrela-
tionship between RA and TGFβ2 during early vertebrate
heart morphogenesis.
Since TGFβ2 gene promoter region does not have RA
response elements [10] which are required for a direct
regulation by RA via its RAR/RXR complexes, an indir-
ect mechanism must be involved. The expression of
TGFβ2 is governed by two AP-1, two AP-2, two Sp1,
and four CRE binding sites located in the promoter of
this gene [33]. An indirect regulation of TGFβ2 by RAmight be achieved by RA affecting one or more of these
binding sites. It is known that the RA/RAR/RXR com-
plex can bind to AP-1 blocking its activity to induce
TGFβ2 expression [34]; discussed in [6]. Recent studies
of amniotic cell membrane explants show that the RA/
RAR/RXR complex can also interact physically with the
transcription factor Sp1 preventing it from binding to its
site in the TGFβ2 promoter [35]. Clearly, further analysis
of the interactions of TGFβ2 promoter elements and
DNA binding proteins in vitro are needed to elucidate
the molecular mechanism of RA-regulated TGFβ2 ex-
pression during embryogenesis.
In preliminary studies with adult chicken heart cells
and human heart cells isolated from the heart biopsies,
we did not observe any effect on TGFβ2 gene expression
when the RA concentration in the media was either in-
creased or decreased (data not shown). This is likely due
to differences in RA/TGFβ2 regulatory interactions in
embryonic and adult cells, reflecting epigenetic changes
during development. DNA methylation at CpG se-
quences may differentially affect the binding of the tran-
scription factors involved in the regulation of TGFβ2
expression, e.g. AP-2 binding might be blocked [36], AP-
1 binding might be stimulated [37], and CRE binding
may be blocked or modified [38]. These observations
emphasize the need for adequate model systems to study
TGFβ2 expression at specific stages of development.
Studies with quail embryos have shown that when the
early embryo is retinoid deficient, TGFβ2 is overex-
pressed in all cell layers in the anterior part of the em-
bryo [14]. Thus, these ectopically elevated TGFβ2 levels
could adversely affect many of its target genes. It was
therefore important to examine RA-regulated develop-
mental genes that have also been linked to TGFβ in
other cells. One of the genes examined was FN, regu-
lated both by RA [21,22] and TGFβ/SMAD [23]. An-
other gene of interest was NEO, a multifunctional
developmental receptor linked to embryonic organogen-
esis [24]. In human fibroblast cell culture FN1 and NEO
are regulated by TGFβ through the SMAD signaling
pathway [23,39]. It was therefore of interest to examine
the expression of these genes in our cell culture as it
might provide insights into the role of TGFβ2 in the
RA-regulated early heart morphogenesis. Since a Gen-
Bank sequence analysis of FN and NEO genes did not
reveal the presence of RARE elements in their pro-
moters, they are not direct RA target genes.
We found that in our chicken HFR cell cultures the
baseline level of FN1gene expression was increased
when RA was added to the cultures in both DMEM and
Endo-Grow media (Figure 5A), however, it was not a
dose-dependent increase. An explanation for this obser-
vation might be that FN1 is relatively insensitive to small
changes of RA concentrations in the environment at this
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are required to affect its expression; the mechanism of
this is not known. In contrast, FN1 was reported to be
down-regulated by RA in mouse embryonic fibroblast
cells NIH-3 T3 [40]. Further studies are needed both in
vivo and in a culture model to clarify the RA/FN interac-
tions during heart formation. It is, however, very likely
that the FN1 expression observed in our HFR cultures is
of biological significance since the expression of various
other genes examined in this in vitro system was similar
to that observed in vivo.
The expression of NEO gene in the cultured chicken
HFR cells would suggest the presence of neuronal cell
subpopulation that might have been derived from the
early neuronal tube region located underneath the HFR
of the embryo and that had not been completely re-
moved during the preparation of the explants. However,
since NEO regulates diverse developmental events [24],
it may also be involved in cardiovascular development.
Support for this hypothesis comes from our observation
that in the cultured chicken HFR cells NEO is regulated
by RA (Figure 5B) and this regulation appears to be via
TGFβ2 signaling, since NEO expression in response to
RA concentration in the Endo-Grow media paralleled
that of TGFβ2 expression (Figures 4 and 5). Thus, our
study is the first to report the novel observation that RA
regulates NEO expression in the vertebrate embryo and
at a critical time of heart morphogenesis. Since GenBank
sequence analysis of this gene did not reveal the pres-
ence of RARE elements in its promoters, we hypothesize
that in the cultured chicken HFR cells NEO is regulated
by RA indirectly through a TGFβ2 signaling pathway.
Although in most systems TGFβ signals are linked to
SMAD transcriptional activity events [41], in ovo studies
with quail embryos suggest that the RA-regulated
TGFβ2 signaling during early heart morphogenesis is
linked to SMAD- independent pathways [14]. Further
studies are needed to determine if the RA-regulated
NEO expression observed in the cultured chicken HFR
cells is linked to heart morphogenesis and to TGFβ2 sig-
naling, and if SMAD transcription factors are involved.
Studies with quail embryos in ovo have also demon-
strated vitamin A requirement for embryonic vasculo-
genesis and for the generation of endothelial cell
progenitors during early heart morphogenesis, suggest-
ing that an insufficiency of endothelial cells may be a
crucial factor in the VAD-related heart malformations
[7,20]. Importantly, these in vivo studies have also re-
vealed that vitamin A is required to build the link be-
tween the primordial heart and its blood supply, i.e. the
cardiac inflow tract [6]. This event most likely involves
VEGF-A which is required for angiogenesis and the
organization of blood vessels [42]. RA-regulated VEGF-
A expression involving TGFβ signaling has beenreported in human embryonic stem cells [43]. The above
observations prompted us to determine if VEGF-A is
expressed in the cultured chicken HFR cells and if it is
regulated by RA. Indeed, in these cultures we observed
VEGF-A expression (Figure 2), which was significantly
enhanced by added RA (Figure 6). It is very likely that
the in vitro observed VEGF-A expression represents the
in ovo situation. Sequence analysis of the VEGF-A pro-
moter revealed two typical RARE sequences therefore
RA might directly modulate VEGF-A mRNA synthesis.
VEGF upregulation by RA has also been observed in
smooth muscle [44] and in adipocytes [45], while Balmer
and Blomhoff reported inhibition of VEGF by RA
[46]. Additionally, studies with the synthetic derivative
CD2409 showed that RA downregulates VEGF-A expres-
sion through activation of AP1 [47]. These contradictory
observations could be explained by species differences
and different cell types used, e.g. human keratinocytes
[48], and tumor endothelial cells [49]. Furthermore, none
of these publications specify which VEGF transcript vari-
ant was used in the studies.
Altogether, the cultured chicken HFR cell model is a
biologically relevant system to examine RA-regulated
vertebrate early heart morphogenesis under conditions
that allow the manipulation of RA activity. Experiments
on RA-regulated genes described here set the basis for
future studies to elucidate the molecular mechanisms in-
volved in vertebrate cardiovascular morphogenesis.
Conclusions
In vertebrate developmental research, relevant in vivo
models are not always accessible and in many instances
in vitro models can provide alternative approaches to ad-
vance the field. We have developed a biologically rele-
vant and valid in vitro primary cell culture model from
early stage chicken heart forming regions that provides
an excellent research tool to study retinoic acid (RA)
regulated molecular mechanisms during vertebrate early
heart morphogenesis under conditions that closely
mimic in vivo heart morphogenesis. We have verified
the usefulness of the in vitro model by confirming pub-
lished in vivo observations regarding the regulation of
TGFβ2 by RA during early heart formation, as well as by
identifying additional RA-regulated genes, i.e. FN, NEO
and VEGF-A that might be linked to early heart mor-
phogenesis. The in vitro model described here will be a
valuable addition to the experimental tools for vertebrate
developmental research.
Methods
Avian heart forming region explant and cell cultures
Freshly fertilized Ross308 chicken eggs (poultry farm
Kekava, Latvia) were incubated for 36–50 h at 37°C and
used to obtain early embryonic tissue. The experiments
Table 2 PCR oligonucleotide sequences used in this study
Gene Primer sequence Product
size (bp)
GeneBank
chicken-β-actin ctgaaccccaaagccaacag,
ccagatccagacggaggatg
214 X00182.1
chicken VEGF gcagagcgcggagttgtc,
gtccaccagggtctcaattgtc
127 NM_001110355
chicken GATA4 cggcctctcttgtgccaact,
gatggacctgctggcgtctt
203 U11887.1
chicken Nkx2.5 accccgcgtcctcttttctc,
cccaccatctccagggtctg
197 NM_205164.1
chicken TGF-β2 cagtgggaagaccccacatc,
tgaatccatttccagccaag
185 X59080.1
chicken FN1 cgcccctaccactctgacac,
cagctctgcaacgtcctcct
175 XM_421868.2
chicken NEO tccggatagctgccatgact,
tggagtccagctcaccacaa
161 U07644.1
chicken HoxB1 aacctctcgccttccctaaa,
agctgcttggtggtgaagtt
191 NM_001080859
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2010/63/EU, Chapter I, Article 1, Paragraphs 3 and 4, as
pertaining to the very early stages of vertebrate develop-
ment. Embryos were dissected under microscope in cold
phosphate buffered saline (PBS) and staged by their so-
mite stage (ss) of development. Heart forming regions
(HFRs) from chicken embryos at 1–2 ss, 3–5 ss and
7–10 ss were separated from the rest of the embryonic tissue,
rinsed shortly in cold PBS, then transferred to cold, sterile
DMEM (Dulbecco’s Modified Eagle Medium, containing no
FBS), containing 1% penicillin/streptomycin and 2% fungi-
zone (all from Invitrogen) to ensure a sterile environment
during dissections. After dissections, explants were washed
with sterile PBS, placed in either DMEM or Endo-Grow
media (see below) and incubated in 24-well plates, one
explant per well for 3 days at 37°C and at 5% CO2.
Dissected explants were also used to obtain cells for
cultivation studies. For primary cell culture studies only
explants from the 3–5 ss embryos were used, as this
stage of avian embryonic development is the critical
stage when heart morphogenesis is initiated and when
the presence of RA is essential. This was corroborated in
preliminary studies with cultured HFR explants from the
3–5 ss embryos as these explants formed a very high
percentage of contractile heart tissue (Table 1). Primary
cultures of 3–5 ss HFR cells were prepared from com-
bined 10–15 explants collected in DMEM containing 1%
penicillin/streptomycin and 2% fungizone, then trypsi-
nized, centrifuged, the pellet suspended in either DMEM
or Endo-Grow media (see below) and the cell suspension
plated. One explant yielded approximately 5 × 104 cells.
Cells were counted and plated on 24-well plates with
2 × 104 – 3 × 104 cells/well. Explanted cells developed
adherent monolayer within 3 d in culture.
The following two media were used in all cultivation
studies: standard DMEM (Dulbecco’s Modified Eagle
Medium) base, supplemented with 10% Fetal Bovine
Serum (FBS) and 1% penicillin/streptomycin (all from
Invitrogen), and endothelial cell growth media base,
Endo-Grow (Millipore/Chemicon), supplemented with
2% FBS, 5 ng/ml Endothelial Growth Factor, 5 ng/ml
basic Fibroblast Growth Factor, 15 ng/ml Insulin-like
Growth Factor, 50 μg/ml ascorbic acid, 1 μg/ml hydro-
cortisone hemisuccinate, 0.75 U/ml heparin sulfate,
10 mM L-glutamine (all from Millipore/Chemicon) and
1% penicillin/streptomycin, according to the manufac-
turer’s protocol.
In studies with RA, both media were supplemented
with all-trans-RA (Sigma) to a final concentration of 10
nM (3 ng/ml) or 100 nM (30 ng/ml). The HFR cell culti-
vation experiments in RA-supplemented media were
replicated 5 times. Control cells were grown in media
without added RA. All manipulations with RA were
made in dim light.Analysis of secreted TGFβ2
The amount of total secreted TGFβ2 protein in medium
was quantified by TGFβ2 DuoSet ELISA (R&D Systems,
Cat.nr. DY302; the antibodies react with avian proteins).
In brief, cell culture supernatants were collected and im-
mediately used for ELISA. Supernatants were incubated
with 1 N HCl at RT for 10 min to activate latent TGFβ2
and neutralized with 1.2 N NaOH in 0.5 M HEPES,
according to manufacturer’s instructions. Assays were
repeated 5 times with triplicate samples. The changes
of secreted TGFβ2 in RA supplemented media were
expressed as fold change of secreted TGFβ2 from control
(media with no RA supplement). Statistical analysis was
performed using GraphPadPrism v 5.0 software.
RT-PCR and real-time PCR analysis
RNA from chicken HFR cell cultures was extracted using TRI-
zol reagent (Invitrogen) according to the manufacturer’s
recommendations. The purity was assessed using Nanodrop
ND-1000 and integrity was assessed by agarose gel electro-
phoresis. First strand cDNA synthesis was performed on total
RNA using RevertAid™ M-MuLV Reverse Transcriptase
(Fermentas). The quality of cDNA was tested in PCR reaction
(25 cycles) with chicken housekeeping gene β-actin primers.
Chicken VEGF-A, GATA4, Nkx2.5 and HoxB1 gene mRNAs
were tested in obtained cDNA by standard PCR reaction
(Veriti, Applied Biosystems), as follows: initial activation at
95°C for 5 min, followed by 30 to 35 cycles of melting at 95°C
for 15 sec, annealing at 58 to 60°C for 20 sec and elongation
at 72°C for 20 sec. All primer sequences are listed in Table 2.
Gene expression levels were quantified by real-time
PCR on ABI Prism 7300 (Applied Biosystems) using Max-
ima SYBR Green/ROX qPCR Master mix (Fermentas). In
brief, the reaction mixture in 20 μl total volume contained
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verse primers (0.4 μM final concentration), 10 μl SYBR
Green Master mix. PCR conditions were as follows: initial
activation step at 95°C for 4 min, 40 cycles each of melting
at 95°C for 15 sec and annealing/extension at 60°C for
40 sec. Assays were performed in duplicate. Relative fold-
changes were quantified using the comparative CT
(ΔΔCT) method [50]. Data were normalized relative to the
housekeeping gene β-actin mRNA expression.
Determination of RA in cell culture media and in embryo
explants by HPLC
The media used in all experiments contained some RA
i.e. from 10% FBS in DMEM and from 2% FBS in Endo-
Grow, therefore it was necessary to determine their RA
concentrations as well as to assess the retinoid levels in
chicken embryo explants and isolated cells.
Explant and cell samples were prepared as described
by Miyagi et al. [51]. Briefly, approximately 7 × 105 cells
were collected by trypsinization, washed with PBS and
centrifuged. Pellet was resuspended and agitated for
1 min in a solution consisting of 500 μl of PBS (pH 7.4),
500 μl ethanol, 225 μl of 2 M KOH and 600 μl n-
hexane. After centrifugation at 15,000 rpm for 5 min,
upper phase and lower phases were collected separately.
Lower (aqueous) phase (500 μl) was mixed with a so-
lution consisting of 450 μl of 2 M HCl, 600 μl of
n-hexane, centrifuged as above and the upper phase col-
lected. Organic solvents were evaporated from collected
fractions, each residue re-dissolved in 200 μl of n-
hexane and subjected to HPLC analysis.
DMEM and Endo-Grow media, each containing 10
nM or 100 nM RA, were used as references for RA de-
tection in FBS batches and in chicken embryo explants
and cells. The relationship between each concentration
and the height of the area under the curve of each peak
was examined by linear least-squares regression analysis.
Retinoids were separated by HPLC on a reverse-phase
Zorbax Eclipse XDB-C18 column 4.6 × 150 mm, 5 μm
(Agilent Technologies, Germany). Column temperature
was 25°C. Mobile phase was prepared by the mixing of
two solutions: A (10% methanol/0.3% acetic acid) and B
(90% methanol/0.3% acetic acid), in a volume ratio of
A:B/1:9. Samples were injected in 100 μL. The mobile
phase flow rate was 1.0 mL/min. RA was detected at
351 nm. Results were evaluated by a ChemStation Plus
(Agilent, Germany). No RA was detected in the explants
and in the heart forming region cells.
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